[Pharmacokinetics and metabolism of fominoben (Noleptan) in man].
D000284:Administration, Oral; D000328:Adult; D000813:Anilides / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D000996:Antitussive Agents / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D001345:Autoradiography; D001711:Biotransformation; D002250:Carbon Radioisotopes / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D002855:Chromatography, Thin Layer; D004231:Diuresis; D004347:Drug Interactions; D005243:Feces / Q000032:analysis; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate; D008744:Methylamines / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D009025:Morpholines / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine
D000813:Anilides; D000996:Antitussive Agents; D002250:Carbon Radioisotopes; D000697:Central Nervous System Stimulants; D008744:Methylamines; D009025:Morpholines